Hematology NewsFour-item prognostic index predicts survival in adult Burkitt lymphomaDecember 16, 2020B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsStudy found dual-targeted CAR T highly active against relapsed/refractory multiple myelomaDecember 15, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsPhase 1 study shows feasibility, safety, efficacy of STAR T cells for ALLDecember 14, 2020T Cell LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsSynthetic lethality: Triple combination is a viable strategy for B-cell malignanciesDecember 11, 2020B Cell LymphomaDLBCLLymphoma & Plasma Cell DisordersCLL
Hematology NewsZUMA-12 study shows frontline axi-cel has substantial activity in high-risk large B-cell lymphomaDecember 11, 2020B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsPediatric regimens better for adolescents/young adults with aggressive B-cell NHLDecember 10, 2020B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsBispecific antibody odronextamab demonstrates durable complete responses in refractory NHLDecember 10, 2020B Cell LymphomaLymphoma & Plasma Cell DisordersDLBCL
Hematology NewsExtended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Patient & Survivor CareCOVID-19 UpdatesLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantMultiple MyelomaMyelodysplastic Syndrome
Hematology NewsFive-minute SC injection of daratumumab in RRMMDecember 9, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsDuvelisib response rate encouraging in phase 2 PRIMO trial of patients with r/r PTCLDecember 7, 2020T Cell LymphomasLymphoma & Plasma Cell Disorders
Oncology PracticeNHS England starts pilot trial of blood test for many cancersDecember 7, 2020Mixed TopicsBreast CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell Disorders
Hematology NewsChildhood Hodgkin survivors have neurocognitive impairmentDecember 7, 2020Hodgkin LymphomaLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsDurable responses with anti-BCMA CAR T-cell for multiple myelomaDecember 6, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsAllogeneic transplant leads to durable remissions in T-cell lymphomasDecember 6, 2020T Cell LymphomasTransplantLymphoma & Plasma Cell Disorders
Hematology NewsZUMA-5: Axi-cel yields high response rate in indolent NHLDecember 6, 2020B Cell LymphomaLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
